Experienced in PIK3CA-Related Overgrowth Spectrum

Lisa Weibel

Zurich, ZH, CH 
Experienced in PIK3CA-Related Overgrowth Spectrum
Zurich, ZH, CH 
OverviewLocationsClinical Research

Overview

Lisa Weibel practices in Zurich, Switzerland. Ms. Weibel is rated as an Experienced expert by MediFind in the treatment of PIK3CA-Related Overgrowth Spectrum. Her top areas of expertise are Localized Scleroderma, Uncombable Hair Syndrome, Nevoid Basal Cell Carcinoma Syndrome, and Netherton Syndrome.

Her clinical research consists of co-authoring 97 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of PIK3CA-Related Overgrowth Spectrum.

Gender
Female

Locations

Zurich, ZH 8032, Switzerland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Outpatient Study Evaluating the Pharmacokinetics, Efficacy, and Safety of Baricitinib in Pediatric Patients With Moderate to Severe Atopic Dermatitis
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Outpatient Study Evaluating the Pharmacokinetics, Efficacy, and Safety of Baricitinib in Pediatric Patients With Moderate to Severe Atopic Dermatitis
Enrollment Status: Active_not_recruiting
Publish Date: April 20, 2025
Intervention Type: Drug
Study Drugs: Baricitinib, Topical Corticosteroid
Study Phase: Phase 3
Investigation of the Genetic Architecture of Linear Localized Scleroderma (LLS) (Linear Morphea) by Whole Exome Sequencing. A Tailored Approach to Test the Hypothesis That LLS is a Genetic Mosaic Condition
Investigation of the Genetic Architecture of Linear Localized Scleroderma (LLS) (Linear Morphea) by Whole Exome Sequencing. A Tailored Approach to Test the Hypothesis That LLS is a Genetic Mosaic Condition
Enrollment Status: Completed
Publish Date: November 10, 2020
Intervention Type: Other
Study Phase: Not Applicable
View 1 Less Clinical Trial

97 Total Publications

A Retrospective Analysis of Ambiguous Spitz Tumors Using Next-Generation Sequencing.
A Retrospective Analysis of Ambiguous Spitz Tumors Using Next-Generation Sequencing.
Journal: Cancers
Published: March 01, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Weibel's expertise for a condition
ConditionClose
    View All 31 Advanced Conditions
    View All 30 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile